Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Bladder Cancer

Free Subscription 26.08.2019 1 Aging (Albany NY) 1 Antioxidants (Basel) 2 Beijing Da Xue Xue Bao Yi Xue Ban 1 Biosci Rep 2 BJU Int 1 BMC Urol 1 Cancer Causes Control 1 Cancer Manag Res 1 Cancers (Basel) 1 Case Rep Oncol 1 Diagn Pathol 1 EBioMedicine 2 Eur Urol 1 Eur Urol Focus 2 Int J Cancer 1 Int J Environ Res Public Health 1 J BUON 1 J Cancer 1 J Endourol 1 J Med Microbiol 1 J Patient Rep Outcomes 1 J Urol 1 Klin Onkol 1 Minerva Urol Nefrol 1 Nat Rev Urol 1 Oncol Lett 1 Oncol Rep 2 Pathologe 1 Phytomedicine 1 Urol Case Rep 1 Urol Oncol 1 Urology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aging (Albany NY)

1. HE A, He S, Peng D, Zhan Y, et al
   Prognostic value of long non-coding RNA signatures in bladder cancer.
   Aging (Albany NY). 2019;11.
   PubMed     Text format     Abstract available
   
   

   
   Antioxidants (Basel)

2. PARK C, Cha HJ, Lee H, Hwang-Bo H, et al
   Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway.
   Antioxidants (Basel). 2019;8.
   PubMed     Text format     Abstract available
   
   

   
   Beijing Da Xue Xue Bao Yi Xue Ban

3. HUANG HW, Yan B, Shang MX, Liu LB, et al
   [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].
   Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:698-705.
   PubMed     Text format     Abstract available
   
   
4. YANG FL, Hong K, Zhao GJ, Liu C, et al
   [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
   Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:615-622.
   PubMed     Text format     Abstract available
   
   

   
   Biosci Rep

5. JI M, Wang Z, Chen J, Gu L, et al
   Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating beta-catenin.
   Biosci Rep. 2019 Aug 20. pii: BSR20190503. doi: 10.1042/BSR20190503.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

6. TAN WS, Sarpong R, Khetrapal P, Rodney S, et al
   Does urinary cytology have a role in haematuria investigations?
   BJU Int. 2019;123:74-81.
   PubMed     Text format     Abstract available
   
   
7. JAIN RK, Grivas P, Pal SK
   Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?
   BJU Int. 2019;124:361-362.
   PubMed     Text format    
   
   

   
   BMC Urol

8. SHARMA M, Goto T, Yang Z, Miyamoto H, et al
   The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy.
   BMC Urol. 2019;19:77.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Causes Control

9. LIM J, Kang SY, Park HS
   Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample.
   Cancer Causes Control. 2019 Aug 20. pii: 10.1007/s10552-019-01219.
   PubMed     Text format    
   
   

   
   Cancer Manag Res

10. ZOU J, Huang R, Li H, Wang B, et al
    Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.
    Cancer Manag Res. 2019;11:6995-7006.
    PubMed     Text format     Abstract available
    
    

    
    Cancers (Basel)

11. GATTA LB, Melocchi L, Bugatti M, Missale F, et al
    Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available
    
    

    
    Case Rep Oncol

12. KAWAHARA T, Takamoto D, Miyoshi Y, Yao M, et al
    Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer.
    Case Rep Oncol. 2019;12:560-563.
    PubMed     Text format     Abstract available
    
    

    
    Diagn Pathol

13. JANSEN I, Lucas M, Savci-Heijink CD, Meijer SL, et al
    Three-dimensional histopathological reconstruction of bladder tumours.
    Diagn Pathol. 2019;14:25.
    PubMed     Text format     Abstract available
    
    

    
    EBioMedicine

14. CHEN Z, He S, Zhan Y, He A, et al
    TGF-beta-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
    EBioMedicine. 2019 Aug 13. pii: S2352-3964(19)30528.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

15. LU M, Zhang Y, Xiao Y
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016.
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30605.
    PubMed     Text format    
    
    
16. KETTUNEN K, Bostrom PJ, Taimen P
    Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30610.
    PubMed     Text format    
    
    

    
    Eur Urol Focus

17. HECK MM, Gschwend JE
    Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit?
    Eur Urol Focus. 2019 Aug 19. pii: S2405-4569(19)30212.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

18. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Reply to: Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32632.
    PubMed     Text format    
    
    
19. KAWADA T
    Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32633.
    PubMed     Text format    
    
    

    
    Int J Environ Res Public Health

20. YANG PJ, Hsieh MJ, Hung TW, Wang SS, et al
    Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development.
    Int J Environ Res Public Health. 2019;16.
    PubMed     Text format     Abstract available
    
    

    
    J BUON

21. HUANG Z, Liu G
    Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer.
    J BUON. 2019;24:1210-1218.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer

22. ZHU CZ, Ting HN, Ng KH, Ong TA, et al
    A review on the accuracy of bladder cancer detection methods.
    J Cancer. 2019;10:4038-4044.
    PubMed     Text format     Abstract available
    
    

    
    J Endourol

23. DARRAD MP, Syed J, Ahmed Z, Syed HA, et al
    Long-Term Prospective Outcomes Of Patients With Non-Muscle Invasive Bladder Cancer Following Holmium Laser Ablation.
    J Endourol. 2019 Aug 21. doi: 10.1089/end.2019.0253.
    PubMed     Text format     Abstract available
    
    

    
    J Med Microbiol

24. BI H, Tian Y, Song C, Li J, et al
    Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer.
    J Med Microbiol. 2019 Aug 16. doi: 10.1099/jmm.0.001058.
    PubMed     Text format     Abstract available
    
    

    
    J Patient Rep Outcomes

25. TAARNHOJ GA, Lindberg H, Johansen C, Pappot H, et al
    Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy.
    J Patient Rep Outcomes. 2019;3:56.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

26. LAGUNA MP
    Re: Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.
    J Urol. 2019;202:456-457.
    PubMed     Text format    
    
    

    
    Klin Onkol

27. ABDOLMALEKI F, Ghafouri-Fard S, Taheri M, Omrani DM, et al
    P21-Associated ncRNA DNA Damage-Activated Expression in Bladder Cancer.
    Klin Onkol. 2019;32:277-280.
    PubMed     Text format     Abstract available
    
    

    
    Minerva Urol Nefrol

28. MURALI-KRISHNAN S, Pang KH, Greco F, Fiori C, et al
    Bladder-sparing treatment in MIBC: where do we stand?
    Minerva Urol Nefrol. 2019;71:101-112.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Urol

29. JOICE GA, Bivalacqua TJ, Kates M
    Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.
    Nat Rev Urol. 2019 Aug 21. pii: 10.1038/s41585-019-0220.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Lett

30. REN Y, Zhao C, He Y, Xu H, et al
    Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.
    Oncol Lett. 2019;18:2050-2058.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

31. LI F, Guo H, Yang Y, Feng M, et al
    Autophagy modulation in bladder cancer development and treatment (Review).
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7286.
    PubMed     Text format     Abstract available
    
    

    
    Pathologe

32. REIS H, Szarvas T, Grunwald V
    [Predictive biomarkers in oncologic uropathology].
    Pathologe. 2019;40:264-275.
    PubMed     Text format     Abstract available
    
    
33. REIS H, Szarvas T
    Urachal cancer-current concepts of a rare cancer.
    Pathologe. 2019;40.
    PubMed     Text format     Abstract available
    
    

    
    Phytomedicine

34. SHIN SS, Park YJ, Hwang B, Park SL, et al
    Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
    Phytomedicine. 2019;64:153069.
    PubMed     Text format     Abstract available
    
    

    
    Urol Case Rep

35. BURITY CRT, Ferreira FT, Veiga AF, Saade RD, et al
    Advanced small-cell bladder cancer into a ureterocele: A case report and literature review.
    Urol Case Rep. 2019;27:100986.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

36. CHEN FV, Koru-Sengul T, Miao F, Jue JS, et al
    Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2019 Aug 14. pii: S1078-1439(19)30251.
    PubMed     Text format     Abstract available
    
    

    
    Urology

37. LIN-BRANDE M, Pearce SM, Ashrafi AN, Nazemi A, et al
    Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Urology. 2019 Aug 14. pii: S0090-4295(19)30721.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: